Explanatory Note
(This note is not part of the Order)
This Order amends the Prescription Only Medicines (Human Use) Order 1997 (“the principal Order”) and provides—
(a)in articles 2 and 4, for the amendment of Schedule 1 to the principal Order (which specifies substances which, if included in medicinal products, make them prescription only medicines, and exemptions from the restrictions in section 58(2) on sale and supply of prescription only medicines), to amend the conditions under which medicinal products containing Azelastine Hydrochloride, Domperidone Maleate, Ibuprofen, Paracetamol and Triamcinolone Acetonide may be sold or supplied otherwise than as prescription only medicines;
(b)in article 4, for the amendment of Schedule 1 to the principal Order to provide that medicinal products containing Domperidone and Lodoxamide Trometamol may be sold or supplied otherwise than as prescription only medicines on the conditions specified;
(c)in article 4, for the insertion in Schedule 1 to the principal Order of the substances Cabergoline, Cefprozil, Indapamide, Lansoprazole, Lercanidipine Hydrochloride, Meloxicam, Pantoprazole Sodium, Penciclovir, Tamsulosin Hydrochloride, Ticlopidine Hydrochloride, Tiludronate Disodium and Toremifene;
(d)in article 3, for the amendment of article 12C of the principal Order (exemption from the restrictions in section 58(2), for the supply or administration of prescription only medicines under a Patient Group Direction by a person lawfully conducting a retail pharmacy business) to provide that prescription only medicines may only be administered under the Direction where they are administered by a designated individual belonging to one of the classes of individual specified in Part III of Schedule 7 to the principal Order; and the amendment of Part III of Schedule 7 to the principal Order, to correct the heading of that Part;
(e)in article 5, for the amendment of paragraph 9 of Part III of Schedule 5 to the principal Order (exemption from the restrictions in section 58(2)(b), for administration by paramedics), to extend the exemption to state registered paramedics, and to add to the list of medicines which may be administered by paramedics, medicines containing the substances Ergometrine Maleate 500mcg per ml with Oxytocin 5 iu per ml, and medicines containing the substances Benzylpenicillin, Frusemide, Metoclopramide, Morphine Sulphate and Streptokinase.
An assessment to the cost to business of complying with this Order has been made, copies of which have been placed in the libraries of both Houses of Parliament. Further copies may be obtained from the Department of Health, Medicines Control Agency, Information Centre, Room 10-202 Market Towers, 1 Nine Elms Lane, London SW8 5NQ.